Skip to main content
CDT Equity Inc. logo

CDT Equity Inc. — Investor Relations & Filings

Ticker · CDT ISIN · US6266422012 US Manufacturing
Filings indexed 289 across all filing types
Latest filing 2024-04-24 Director's Dealing
Country US United States of America
Listing US CDT

About CDT Equity Inc.

https://www.cdtequity.com/

CDT Equity Inc., formerly Conduit Pharmaceuticals Inc., is a data-driven, clinical-stage biopharmaceutical development company. It focuses on identifying, enhancing, and advancing high-potential therapeutic assets to address unmet medical needs. The company leverages an agile platform that utilizes artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. Its strategy involves creating value through strategic partnerships, licensing, and mergers and acquisitions, positioning itself as a platform for innovation.

Recent filings

Filing Released Lang Actions
Director's Dealing 2024
Director's Dealing
2024-04-24 English
Director's Dealing 2024
Director's Dealing
2024-04-24 English
Director's Dealing 2024
Director's Dealing
2024-04-24 English
Annual Report 2023
Annual Report FY 2023
2024-04-16 English
Regulatory Filings 2024
Regulatory Filings
2024-04-16 English
Regulatory Filings 2024
Regulatory Filings
2024-04-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.